TIGECYCLINE VERSUS COLISTIN IN THE TREATMENT OF CARBAPENEM-RESISTANT ACINETOBACTER BAUMANNII OSTEOMYELITIS

P. Oliveira,V.C. Carvalho,E S Saconi,M. Leonhardt,Kodi Edson Kojima,Jorge dos Santos Silva

TIGECYCLINE VERSUS COLISTIN IN THE TREATMENT OF CARBAPENEM-RESISTANT ACINETOBACTER BAUMANNII OSTEOMYELITIS

2019

P. Oliveira
V.C. Carvalho
E S Saconi
M. Leonhardt
Kodi Edson Kojima
Jorge dos Santos Silva

Aim To compare outcomes and incidence of adverse events (AE) of colistin versus tigecycline for treatment of patients with carbapenem-resistant Acinetobacter baumannii (CRAB) osteomyelitis. Method ...

Keywords:

Incidence (epidemiology)
Osteomyelitis
Tigecycline
Acinetobacter baumannii
Colistin
Internal medicine
Carbapenem resistant Acinetobacter baumannii
Adverse effect
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations